Tokyo Tape
Sign in
← Carna Biosciences

Quarterly report · Q3

4572.TEDINET S100S238
Period2023-01-01 → 2023-09-30
Filed2023-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥711m2023-01-01 → 2023-09-30Cons.Net sales
Revenue¥1.4bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2022-01-01 → 2022-09-30Cons.Net sales
Operating income−¥1.2bn2023-01-01 → 2023-09-30Cons.Operating income
Operating income−¥754m2022-01-01 → 2022-09-30Cons.Operating income
Ordinary income−¥1.2bn2023-01-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥1.3bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥736m2022-01-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥1.2bn2023-01-01 → 2023-09-30Cons.Income before income taxes
Profit before tax−¥779m2022-01-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥1.2bn2023-01-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.3bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥795m2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥1.2bn2023-01-01 → 2023-09-30Cons.Profit loss
Net income−¥795m2022-01-01 → 2022-09-30Cons.Profit loss
Total assets¥4.2bnat 2023-09-30Cons.Assets
Total assets¥4.3bnat 2022-12-31Cons.Assets
Total assets¥4.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥376mat 2023-09-30Cons.Liabilities
Total liabilities¥625mat 2022-12-31Cons.Liabilities
Net assets / equity¥3.8bnat 2023-09-30Cons.Net assets
Net assets / equity¥3.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥3.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.4bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥-73.742023-01-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-20.132023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-99.12022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-58.562022-01-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-31.922022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio91.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio85.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio86.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentsegment profit2023-01-01 → 2023-09-30−¥1.4bn
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2023-01-01 → 2023-09-30¥711m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2023-01-01 → 2023-09-30¥711m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2023-01-01 → 2023-09-30¥218m
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥286m
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥286m
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-09-30−¥1.1bn
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥810m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥810m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-09-30¥336m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 306
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member7100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0004
Number of shares held in own name treasury shares etcCurrentQuarterInstant7100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant7100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0004
Cash and depositsPrior1YearInstant3379048000JPY
Cash and depositsCurrentQuarterInstant3390745000JPY
Accounts receivable tradePrior1YearInstant182426000JPY
Accounts receivable tradeCurrentQuarterInstant129906000JPY
Merchandise and finished goodsPrior1YearInstant84450000JPY
Merchandise and finished goodsCurrentQuarterInstant89788000JPY
Work in processPrior1YearInstant5918000JPY
Work in processCurrentQuarterInstant10664000JPY
Raw materials and suppliesPrior1YearInstant28163000JPY
Raw materials and suppliesCurrentQuarterInstant39090000JPY
Other caPrior1YearInstant424308000JPY
Other caCurrentQuarterInstant390786000JPY
Current assetsPrior1YearInstant4104316000JPY
Current assetsCurrentQuarterInstant4050982000JPY
Property plant and equipmentPrior1YearInstant100231000JPY
Property plant and equipmentCurrentQuarterInstant82379000JPY
Intangible assetsPrior1YearInstant1915000JPY
Intangible assetsCurrentQuarterInstant1297000JPY
Investments and other assetsPrior1YearInstant59990000JPY
Investments and other assetsCurrentQuarterInstant57577000JPY
Noncurrent assetsPrior1YearInstant162137000JPY
Noncurrent assetsCurrentQuarterInstant141254000JPY
AssetsPrior1YearInstant4266453000JPY
AssetsCurrentQuarterInstant4192236000JPY
Accounts payable tradePrior1YearInstant1962000JPY
Accounts payable tradeCurrentQuarterInstant－JPY
Current portion of bondsPrior1YearInstant32000000JPY
Current portion of bondsCurrentQuarterInstant－JPY
Current portion of long term loans payablePrior1YearInstant119988000JPY
Current portion of long term loans payableCurrentQuarterInstant119988000JPY
Accounts payable otherPrior1YearInstant235136000JPY
Accounts payable otherCurrentQuarterInstant107398000JPY
Income taxes payablePrior1YearInstant30664000JPY
Income taxes payableCurrentQuarterInstant28604000JPY
Other clPrior1YearInstant16654000JPY
Other clCurrentQuarterInstant21309000JPY
Current liabilitiesPrior1YearInstant436407000JPY
Current liabilitiesCurrentQuarterInstant277299000JPY
Long term loans payablePrior1YearInstant148402000JPY
Long term loans payableCurrentQuarterInstant58411000JPY
Asset retirement obligations nclPrior1YearInstant38040000JPY
Asset retirement obligations nclCurrentQuarterInstant38503000JPY
Other nclPrior1YearInstant1759000JPY
Other nclCurrentQuarterInstant1403000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass